» Articles » PMID: 27223641

Colchicine to Reduce Atrial Fibrillation in the Postoperative Period of Myocardial Revascularization

Overview
Date 2016 May 26
PMID 27223641
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The high prevalence of atrial fibrillation (AF) in the postoperative period of myocardial revascularization surgery increases morbidity and mortality.

Objective: To assess the efficacy of colchicine to prevent AF in the postoperative period of myocardial revascularization surgery, the impact of AF on hospital length of stay and death, and to identify its risk factors.

Methods: Between May 2012 and November 2013, 140 patients submitted to myocardial revascularization surgery were randomized, 69 to the control group and 71 to the colchicine group. Colchicine was used at the dose of 1 mg orally, twice daily, preoperatively, and of 0.5 mg, twice daily, until hospital discharge. A single dose of 1 mg was administered to those admitted 12 hours or less before surgery.

Results: The primary endpoint was AF rate in the postoperative period of myocardial revascularization surgery. Colchicine group patients showed no reduction in AF incidence as compared to control group patients (7.04% versus 13.04%, respectively; p = 0.271). There was no statistically significant difference between the groups regarding death from any cause rate (5.6% versus 10.1%; p = 0,363) and hospital length of stay (14.5 ± 11.5 versus 13.3 ± 9.4 days; p = 0.490). However, colchicine group patients had a higher infection rate (26.8% versus 8.7%; p = 0.007).

Conclusion: The use of colchicine to prevent AF after myocardial revascularization surgery was not effective in the present study. Brazilian Registry of Clinical Trials number RBR-556dhr.

Citing Articles

[Colchicine-Phoenix from the ashes].

Lunzer R, Delle-Karth G, Zeitlinger M, Prager M, Pracher L Wien Klin Wochenschr. 2025; 137(Suppl 1):1-33.

PMID: 39912853 PMC: 11802715. DOI: 10.1007/s00508-024-02490-7.


The Action of Colchicine in Patients with Metabolic Syndrome and Obesity: Perspectives and Challenges.

Bulhoes F, Assis G, Caze A, Barros-Pereira J, Laguna G, Improta-Caria A Metabolites. 2024; 14(11).

PMID: 39590865 PMC: 11596755. DOI: 10.3390/metabo14110629.


Efficacy of Colchicine for Prevention of Stroke and Adverse Cardiovascular Events: A Meta-analysis of 16 Randomized Controlled Trials.

Jaiswal V, Deb N, Hanif M, Wajid Z, Nasir Y, Naz S Am J Cardiovasc Drugs. 2024; 25(1):83-93.

PMID: 39460903 DOI: 10.1007/s40256-024-00689-7.


Colchicine for Prevention of Post-Cardiac Surgery and Post-Pulmonary Vein Isolation Atrial Fibrillation: A Meta-Analysis.

Wang X, Peng X, Li Y, Lin R, Liu X, Ruan Y Rev Cardiovasc Med. 2024; 23(12):387.

PMID: 39076666 PMC: 11270460. DOI: 10.31083/j.rcm2312387.


The relationship between atrial fibrillation and NLRP3 inflammasome: a gut microbiota perspective.

Xing Y, Yan L, Li X, Xu Z, Wu X, Gao H Front Immunol. 2023; 14:1273524.

PMID: 38077349 PMC: 10703043. DOI: 10.3389/fimmu.2023.1273524.


References
1.
Deftereos S, Giannopoulos G, Papoutsidakis N, Panagopoulou V, Kossyvakis C, Raisakis K . Colchicine and the heart: pushing the envelope. J Am Coll Cardiol. 2013; 62(20):1817-25. DOI: 10.1016/j.jacc.2013.08.726. View

2.
Anselmi A, Possati G, Gaudino M . Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation?. Ann Thorac Surg. 2009; 88(1):326-33. DOI: 10.1016/j.athoracsur.2009.01.031. View

3.
Hashemzadeh K, Dehdilani M, Dehdilani M . Does Off-pump Coronary Artery Bypass Reduce the Prevalence ofAtrial Fibrillation?. J Cardiovasc Thorac Res. 2013; 5(2):45-9. PMC: 3825388. DOI: 10.5681/jcvtr.2013.010. View

4.
Mitchell L . Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery. Can J Cardiol. 2011; 27(1):91-7. DOI: 10.1016/j.cjca.2010.11.005. View

5.
Imazio M, Brucato A, Ferrazzi P, Rovere M, Gandino A, Cemin R . Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011; 124(21):2290-5. DOI: 10.1161/CIRCULATIONAHA.111.026153. View